Cell Death and Disease (Dec 2023)

PDIA6, which is regulated by TRPM2-AS/miR-424-5p axis, promotes endometrial cancer progression via TGF-beta pathway

  • Pengling Wang,
  • Tianli Zhang,
  • Nan Jiang,
  • Kun Wang,
  • Liping Feng,
  • Ting Liu,
  • Xingsheng Yang

DOI
https://doi.org/10.1038/s41419-023-06297-8
Journal volume & issue
Vol. 14, no. 12
pp. 1 – 12

Abstract

Read online

Abstract PDIA6 have been reported to be involved in a variety of cancers, however, the underlying role in endometrial cancer is still unclear. In this study, we aimed to study the function of PDIA6 in endometrial cancer. Firstly, we verified that PDIA6 was significantly upregulated in endometrial cancer, which was correlated with the progression of endometrial cancer patients. Furthermore, we identified PDIA6 significantly altered the ability of endometrial cancer cells to proliferate and metastasize. In addition, our result illustrated the oncogene effects of PDIA6 in promoting malignant biological behavior of endometrial cancer cells by regulating TGF-β pathway and being modulated by TRPM2-AS/miR-424-5p axis for the first time. Taken together, this study suggested that PDIA6 may be a new candidate target for endometrial cancer therapy.